These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25706885)

  • 1. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
    Pole JD; Darmawikarta D; Gassas A; Ali M; Egler M; Greenberg ML; Doyle J; Nathan PC; Schechter T
    Bone Marrow Transplant; 2015 May; 50(5):721-6. PubMed ID: 25706885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
    Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
    Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
    PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia.
    Westerveld ASR; Roesthuis P; van der Pal HJH; Bresters D; Bierings M; Loonen J; de Vries ACH; Louwerens M; Koopman MMW; van den Heuvel-Eibrink MM; van der Heiden-van der Loo M; Hoogerbrugge P; Janssens GO; de Krijger RR; Ronckers CM; Pieters R; Kremer LCM; Teepen JC
    Blood Cancer J; 2024 Aug; 14(1):150. PubMed ID: 39198413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
    Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
    Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late mortality after hematopoietic SCT for a childhood malignancy.
    Schechter T; Pole JD; Darmawikarta D; Doyle J; Ali M; Egeler M; Gassas A; Irwin MS; Greenberg M; Nathan PC
    Bone Marrow Transplant; 2013 Oct; 48(10):1291-5. PubMed ID: 23665822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction.
    Zamora-Ortiz G; Velázquez-Sánchez-de-Cima S; Ponce-de-León S; Gutiérrez-Aguirre CH; Ruiz-Delgado GJ; Gomez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2014 Dec; 19(8):435-40. PubMed ID: 24552480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.
    Faraci M; Bagnasco F; Corti P; Messina C; Fagioli F; Podda M; Prete A; Caselli D; Lanino E; Dini G; Rondelli R; Haupt R;
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1271-6. PubMed ID: 19747635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.
    Song JS; London WB; Hawryluk EB; Guo D; Sridharan M; Fisher DE; Lehmann LE; Duncan CN; Huang JT
    Bone Marrow Transplant; 2017 Jul; 52(7):989-997. PubMed ID: 28368380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies after autologous hematopoietic cell transplantation in children.
    Danner-Koptik KE; Majhail NS; Brazauskas R; Wang Z; Buchbinder D; Cahn JY; Dilley KJ; Frangoul HA; Gross TG; Hale GA; Hayashi RJ; Hijiya N; Kamble RT; Lazarus HM; Marks DI; Reddy V; Savani BN; Warwick AB; Wingard JR; Wood WA; Sorror ML; Jacobsohn DA
    Bone Marrow Transplant; 2013 Mar; 48(3):363-8. PubMed ID: 22964594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
    Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
    Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Fujita N; Kobayashi R; Atsuta Y; Iwasaki F; Suzumiya J; Sasahara Y; Inoue M; Koh K; Hori T; Goto H; Ichinohe T; Hashii Y; Kato K; Suzuki R; Mitsui T
    Int J Hematol; 2019 Apr; 109(4):483-490. PubMed ID: 30701466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
    Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
    Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
    JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.
    Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
    Leukemia; 2015 Feb; 29(2):441-7. PubMed ID: 24962016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.